
1 - 10 employees
Founded 2017
🏥 Healthcare
🧬 Biotechnology
💊 Pharmaceuticals
💰 $100M Private Equity Round on 2022-04
Healthcare • Biotechnology • Pharmaceuticals
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel monoclonal antibodies to treat severe autoimmune and inflammatory diseases. The company leverages advanced antibody engineering technologies to create next-generation complement therapeutics with improved selectivity and potency. Its lead program, DNTH103, is a monoclonal antibody targeting the classical complement pathway for conditions such as generalized Myasthenia Gravis, Multifocal Motor Neuropathy, and Chronic Inflammatory Demyelinating Polyneuropathy. Based in New York City and Waltham, Massachusetts, Dianthus aims to deliver transformative medicinal therapies by addressing unmet needs in autoimmune treatment.
🕒 5 days ago
Associate Director guiding QSP, PopPK, and exposure-response modeling for Dianthus Therapeutics’ autoimmune and neuromuscular therapies. Supporting dose selection, formulation bridging, and regulatory strategy.
🇺🇸 United States – Remote
💰 $100M Private Equity Round on 2022-04
⏰ Full Time
🟠 Senior
👨⚕️ Medical Director
👻 Ghost score 18%
🕒 5 days ago
Associate Director overseeing global clinical trial operations for Dianthus Therapeutics’ autoimmune disease therapies. Driving study strategy, execution, compliance, and resource management across clinical programs.
🇺🇸 United States – Remote
💰 $100M Private Equity Round on 2022-04
⏰ Full Time
🟠 Senior
🏥 Clinical Operations
👻 Ghost score 18%
🕒 August 4
Associate Director shaping commercial insights, competitive intelligence, and forecasts for Dianthus autoimmune and rare-disease therapies. Supporting development, portfolio, and commercialization strategy across DNTH212 and claseprubart.
🇺🇸 United States – Remote
💰 $100M Private Equity Round on 2022-04
⏰ Full Time
🟠 Senior
👔 Director
👻 Ghost score 18%
🕒 July 30
Senior Clinical Data Manager overseeing data management activities for clinical trials. Ensuring delivery of high-quality, regulatory-compliant data and collaborating with cross-functional teams.
🇺🇸 United States – Remote
💰 $100M Private Equity Round on 2022-04
⏰ Full Time
🟠 Senior
🧪 Clinical Research
👻 Ghost score 18%
🕒 July 22
Director/Senior Director, Program Management overseeing inter-disciplinary drug development programs at Dianthus Therapeutics. Collaborating with scientists and stakeholders to develop strategies and deliver results.
🇺🇸 United States – Remote
💰 $100M Private Equity Round on 2022-04
⏰ Full Time
🟠 Senior
👷♀️ Project Manager
👻 Ghost score 18%
🕒 July 7
Systems Administrator focusing on Identity and Access Management for biotech company Dianthus Therapeutics. Responsible for managing access governance, identity lifecycle, and ensuring secure operations.
🇺🇸 United States – Remote
💰 $100M Private Equity Round on 2022-04
⏰ Full Time
🟡 Mid-level
🟠 Senior
⌨️ Systems Administrator
👻 Ghost score 18%
🕒 July 6
Associate Director/Director leading external manufacturing for CMC of drug products at Dianthus Therapeutics. Focusing on monoclonal antibodies and ensuring compliance with regulatory standards.
🇺🇸 United States – Remote
💰 $100M Private Equity Round on 2022-04
⏰ Full Time
🟠 Senior
👔 Director
👻 Ghost score 18%
🕒 May 26
Associate Director leading formulation strategies for bispecific fusion protein development at Dianthus Therapeutics. Focus on protein stability and manufacturability in clinical development.
🇺🇸 United States – Remote
💰 $100M Private Equity Round on 2022-04
⏰ Full Time
🟠 Senior
👔 Director
👻 Ghost score 25%